Fihman V - Search Results

1

Gram-negative bacteremia: which empirical antibiotic therapy?

Shoai Tehrani M, Hajage D, Fihman V, Tankovic J, Cau S, Day N, Visseaux C, Carbonnelle E, Kouatchet A, Cattoir V, Nhan TX, Corvec S, Jacquier H, Jauréguy F, Le Monnier A, Morand P, Zahar JR; on behalf the Groupe de microbiologie clinique. Shoai Tehrani M, et al. Among authors: fihman v. Med Mal Infect. 2014 Apr;44(4):159-66. doi: 10.1016/j.medmal.2014.01.013. Epub 2014 Mar 21. Med Mal Infect. 2014. PMID: 24661557

2

Appearance of aac(6')-Ib-cr gene among extended-spectrum beta-lactamase-producing Enterobacteriaceae in a French hospital.

Fihman V, Lartigue MF, Jacquier H, Meunier F, Schnepf N, Raskine L, Riahi J, Sanson-le Pors MJ, Berçot B. Fihman V, et al. J Infect. 2008 Jun;56(6):454-9. doi: 10.1016/j.jinf.2008.03.010. Epub 2008 Apr 28. J Infect. 2008. PMID: 18440645

3

Revisited distribution of nonfermenting Gram-negative bacilli clinical isolates.

Jacquier H, Carbonnelle E, Corvec S, Illiaquer M, Le Monnier A, Bille E, Zahar JR, Beretti JL, Jauréguy F, Fihman V, Tankovic J, Cattoir V. Jacquier H, et al. Among authors: fihman v. Eur J Clin Microbiol Infect Dis. 2011 Dec;30(12):1579-86. doi: 10.1007/s10096-011-1263-5. Epub 2011 Apr 21. Eur J Clin Microbiol Infect Dis. 2011. PMID: 21509476

4

Stenotrophomonas maltophilia--the most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: a prospective multicenter study.

Fihman V, Le Monnier A, Corvec S, Jaureguy F, Tankovic J, Jacquier H, Carbonnelle E, Bille E, Illiaquer M, Cattoir V, Zahar JR. Fihman V, et al. J Infect. 2012 Apr;64(4):391-8. doi: 10.1016/j.jinf.2012.01.001. Epub 2012 Jan 5. J Infect. 2012. PMID: 22245400

5

In vitro antimicrobial activity of "last-resort" antibiotics against unusual nonfermenting Gram-negative bacilli clinical isolates.

Jacquier H, Le Monnier A, Carbonnelle E, Corvec S, Illiaquer M, Bille E, Zahar JR, Jauréguy F, Fihman V, Tankovic J, Cattoir V; Gmc Study Group. Jacquier H, et al. Among authors: fihman v. Microb Drug Resist. 2012 Aug;18(4):396-401. doi: 10.1089/mdr.2011.0195. Epub 2012 Feb 15. Microb Drug Resist. 2012. PMID: 22335615

6

Clinical spectrum of urine cultures positive for ESBL-producing Escherichia coli in hospitalized patients and impact on antibiotic use.

Lepeule R, Leflon-Guibout V, Vanjak D, Zahar JR, Lafaurie M, Besson C, Lefort A; Groupe des Référents en Infectiologie d’Île-de-France (GRIF). Lepeule R, et al. Med Mal Infect. 2014 Dec;44(11-12):530-4. doi: 10.1016/j.medmal.2014.09.004. Epub 2014 Oct 11. Med Mal Infect. 2014. PMID: 25311839

7

[Prevalence of Clostridium difficile infection in hospitalized patients with diarrhea: results of a French prospective multicenter bi-annual point prevalence study].

Barbut F, Ramé L, Petit A, Suzon L, de Chevigny A, Eckert C; pour le réseau français EUCLID. Barbut F, et al. Presse Med. 2015 Apr;44(4 Pt 1):e75-83. doi: 10.1016/j.lpm.2014.09.021. Epub 2015 Feb 28. Presse Med. 2015. PMID: 25737062 French.

8

Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals.

Le Monnier A, Duburcq A, Zahar JR, Corvec S, Guillard T, Cattoir V, Woerther PL, Fihman V, Lalande V, Jacquier H, Mizrahi A, Farfour E, Morand P, Marcadé G, Coulomb S, Torreton E, Fagnani F, Barbut F; GMC Study Group. Le Monnier A, et al. Among authors: fihman v. J Hosp Infect. 2015 Oct;91(2):117-22. doi: 10.1016/j.jhin.2015.06.017. Epub 2015 Jul 22. J Hosp Infect. 2015. PMID: 26253518

9

Five-year trends for ventilator-associated pneumonia: Correlation between microbiological findings and antimicrobial drug consumption.

Fihman V, Messika J, Hajage D, Tournier V, Gaudry S, Magdoud F, Barnaud G, Billard-Pomares T, Branger C, Dreyfuss D, Ricard JD. Fihman V, et al. Int J Antimicrob Agents. 2015 Nov;46(5):518-25. doi: 10.1016/j.ijantimicag.2015.07.010. Epub 2015 Aug 19. Int J Antimicrob Agents. 2015. PMID: 26358970

10

Antibiotic use and good practice in 314 French hospitals: The 2010 SPA2 prevalence study.

Alfandari S, Robert J, Péan Y, Rabaud C, Bedos JP, Varon E, Lepape A, Bru JP, Gauzit R; French Infectious Diseases Society (French acronym SPILF), the French National Observatory for Epidemiology of Bacterial Resistance to Antibiotics (ONERBA), and the SPA2 group. Alfandari S, et al. Med Mal Infect. 2015 Nov-Dec;45(11-12):475-80. doi: 10.1016/j.medmal.2015.10.001. Epub 2015 Nov 21. Med Mal Infect. 2015. PMID: 26612602

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters